Abiraterone acetate
- Product NDC
- 64679-021
- 11-digit product format
- 646790021
- Labeler code
- 64679
- Product ID
- 64679-021_6a5aa169-f0f0-432b-b0d2-4f5f0a491cec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Abiraterone acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Wockhardt USA LLC.
- Application
- ANDA208380
- Marketing category
- ANDA
- Marketing start
- 2019-02-27
- Marketing end
- 0000-00-00
- Substance
- ABIRATERONE ACETATE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Cytochrome P450 17A1 Inhibitors [MoA],Cytochrome P450 17A1 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64679-021-01 | 64679002101 | 120 TABLET in 1 BOTTLE (64679-021-01) | 120 tablet | 2019-02-27 | 0000-00-00 | No | No | Current |